Richard Segal

Partner

+1 617 937 2332
rsegal@cooley.com

Richard Segal represents high growth companies, investment banking firms and venture capital firms in public offerings and private placements of securities, with a focus on the technology and life sciences sectors. In addition to a robust domestic practice, he has significant experience in transactions involving foreign issuer seeking to access the U.S. capital markets. Rich also regularly counsels both U.S. and non-U.S. publicly-held companies with respect to corporate governance, SEC reporting and securities law compliance and advises private companies on a wide variety of general corporate and securities matters.

Download full bio

Experience

  • Innate Pharma - $79 Million IPO 

  • SpringWorks Therapeutics – $186 Million IPO  

  • Bellus Health – $70 Million IPO  

  • Karuna Therapeutics $103 million IPO 

  • Morphic Therapeutics - $104 Million IPO 

  • View all

Education

  • Boston College Law School
    JD, cum laude, 2009

  • Dartmouth College
    AB, cum laude, 2005


Admissions & Credentials

Massachusetts

Rankings & Accolades

    Massachusetts Super Lawyers: Rising Star – Securities & Corporate Finance (2013 – 2016)

Contact

+1 617 937 2332 office
rsegal@cooley.com

500 Boylston Street
14th Floor
Boston, MA 02116-3736